roxifiban has been researched along with fibrin in 2 studies
| Studies (roxifiban) | Trials (roxifiban) | Recent Studies (post-2010) (roxifiban) | Studies (fibrin) | Trials (fibrin) | Recent Studies (post-2010) (fibrin) |
|---|---|---|---|---|---|
| 40 | 7 | 1 | 15,994 | 328 | 3,808 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Forsythe, MS; Khurana, S; Mousa, SA | 1 |
| Bozarth, JM; Feuerstein, GZ; Mousa, SA; Seiffert, D | 1 |
1 trial(s) available for roxifiban and fibrin
| Article | Year |
|---|---|
Using thrombelastography to determine the efficacy of the platelet glycoprotein IIb/IIIa antagonist, roxifiban, on platelet/fibrin-mediated clot dynamics in humans.
Topics: Amidines; Aspirin; Blood Coagulation; Calcium Chloride; Cross-Over Studies; Fibrin; Humans; Isoxazoles; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Reference Values; Thrombelastography | 2005 |
1 other study(ies) available for roxifiban and fibrin
| Article | Year |
|---|---|
Comparative in vitro efficacy of different platelet glycoprotein IIb/IIIa antagonists on platelet-mediated clot strength induced by tissue factor with use of thromboelastography: differentiation among glycoprotein IIb/IIIa antagonists.
Topics: Abciximab; Alanine; Amidines; Antibodies, Monoclonal; Blood Coagulation; Blood Platelets; Elasticity; Fibrin; Humans; Immunoglobulin Fab Fragments; Isoxazoles; Nephelometry and Turbidimetry; Oxazoles; Platelet Activation; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Recombinant Proteins; Sulfonamides; Thrombelastography; Thromboplastin; Viscosity | 2000 |